seffalair spiromax
teva b.v. - fluticasone propionate, salmeterol xinafoate - astma - drogy obštrukčnej choroby dýchacích ciest, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.
capecitabine glenmark 500 mg filmom obalené tablety
glenmark pharmaceuticals s.r.o., Česká republika - kapecitabín - 44 - cytostatica
coloxet 500 mg
egis pharmaceuticals plc, maďarsko - kapecitabín - 44 - cytostatica
capecitalox 500 mg
mylan ireland limited, Írsko - kapecitabín - 44 - cytostatica
taxier 100 mg
zentiva a.s., slovensko - sildenafil - 83 - vasodilatantia
taxier 50 mg
zentiva a.s., slovensko - sildenafil - 83 - vasodilatantia
capecitabine pharmagen 500 mg filmom obalené tablety
pharmagen cz s.r.o., Česká republika - kapecitabín - 44 - cytostatica
capecitabine fresenius kabi 500 mg filmom obalené tablety
fresenius kabi oncology plc. - kapecitabín - 44 - cytostatica
benfogamma 300
wörwag pharma gmbh & co. kg, nemecko - benfotiamín - 86 - vitamina, vitagena
flixotide diskus 500 µg
glaxosmithkline trading services limited, Írsko - flutikazón - 14 - bronchodilatantia, antiasthmatica